Phase III trial of EndoTAG-1 in patients with pancreatic cancer.

Trial Profile

Phase III trial of EndoTAG-1 in patients with pancreatic cancer.

Planning
Phase of Trial: Phase III

Latest Information Update: 11 Nov 2011

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Pancreatic cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors MediGene AG
  • Most Recent Events

    • 11 Nov 2011 Trial not yet initiated.
    • 17 Dec 2009 New trial record
    • 15 Dec 2009 This trial is anticipated to begin in the first half of 2011 according to a MediGene AG media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top